COCRYSTAL PHARMA, INC. Operating Expenses
COCRYSTAL PHARMA, INC. (COCP) reported Operating Expenses of $3.29 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- COCRYSTAL PHARMA, INC. operating expenses for the quarter ending 2026-06-30 was $3.29M, a 56.02% increase year-over-year.
- COCRYSTAL PHARMA, INC. operating expenses for the quarter ending 2026-03-31 was $2.58M, a 10.25% increase year-over-year.
- COCRYSTAL PHARMA, INC. operating expenses for the quarter ending 2025-12-31 was $2.48M, a 23.19% decline year-over-year.
- COCRYSTAL PHARMA, INC. operating expenses for the quarter ending 2025-09-30 was $2.09M, a 58.57% decline year-over-year.
- COCRYSTAL PHARMA, INC. operating expenses for fiscal 2025 was $9.02M, a 49.55% decline from fiscal 2024.
- COCRYSTAL PHARMA, INC. operating expenses for fiscal 2024 was $17.88M, a 3.67% decline from fiscal 2023.
- COCRYSTAL PHARMA, INC. operating expenses for fiscal 2023 was $18.56M, a 52.20% decline from fiscal 2022.
- COCRYSTAL PHARMA, INC. operating expenses for fiscal 2022 was $38.83M, a 173.04% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 87 month |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.29M 10-Q · filed 2026-08-13 | $5.87M 10-Q · filed 2026-08-13 | $8.35M derived: sum of 3 quarters · filed 2026-08-13 | $10.44M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2026-03-31 | $2.58M 10-Q · filed 2026-05-15 | $5.06M derived: sum of 2 quarters · filed 2026-05-15 | $7.15M derived: sum of 3 quarters · filed 2026-05-15 | $9.26M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.57M derived: sum of 2 quarters · filed 2026-03-31 | $6.68M derived: sum of 3 quarters · filed 2026-08-13 | $9.02M 10-K · filed 2026-03-31 | |||||
| 2025-09-30 | $2.09M 10-Q · filed 2025-11-14 | $4.20M derived: sum of 2 quarters · filed 2026-08-13 | $6.54M 10-Q · filed 2025-11-14 | $9.77M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-06-30 | $2.11M 10-Q · filed 2026-08-13 | $4.45M 10-Q · filed 2026-08-13 | $7.68M derived: sum of 3 quarters · filed 2026-08-13 | $12.72M derived: sum of 4 quarters · filed 2026-08-13 | |||||
| 2025-03-31 | $2.34M 10-Q · filed 2026-05-15 | $5.57M derived: sum of 2 quarters · filed 2026-05-15 | $10.61M derived: sum of 3 quarters · filed 2026-05-15 | $16.06M derived: sum of 4 quarters · filed 2026-05-15 | |||||
| 2024-12-31 | $3.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $8.27M derived: sum of 2 quarters · filed 2026-03-31 | $13.72M derived: sum of 3 quarters · filed 2026-03-31 | $17.88M 10-K · filed 2026-03-31 | |||||
| 2024-09-30 | $5.04M 10-Q · filed 2025-11-14 | $10.49M derived: sum of 2 quarters · filed 2025-11-14 | $14.65M 10-Q · filed 2025-11-14 | $19.31M derived: sum of 4 quarters · filed 2025-11-14 | |||||
| 2024-06-30 | $5.45M 10-Q · filed 2025-08-14 | $9.61M 10-Q · filed 2025-08-14 | $14.27M derived: sum of 3 quarters · filed 2025-08-14 | $18.71M derived: sum of 4 quarters · filed 2025-08-14 | |||||
| 2024-03-31 | $4.16M 10-Q · filed 2025-05-15 | $8.82M derived: sum of 2 quarters · filed 2025-05-15 | $13.27M derived: sum of 3 quarters · filed 2025-05-15 | $17.61M derived: sum of 4 quarters · filed 2025-05-15 | |||||
| 2023-12-31 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $9.11M derived: sum of 2 quarters · filed 2025-03-31 | $13.45M derived: sum of 3 quarters · filed 2025-03-31 | $18.56M 10-K · filed 2025-03-31 | |||||
| 2023-09-30 | $4.44M 10-Q · filed 2024-11-13 | $8.78M derived: sum of 2 quarters · filed 2024-11-13 | $13.89M 10-Q · filed 2024-11-13 | $18.39M derived: sum of 4 quarters · filed 2024-11-13 | |||||
| 2023-06-30 | $4.34M 10-Q · filed 2024-08-14 | $9.45M 10-Q · filed 2024-08-14 | $13.95M derived: sum of 3 quarters · filed 2024-08-14 | $19.65M derived: sum of 4 quarters · filed 2024-08-14 | |||||
| 2023-03-31 | $5.11M 10-Q · filed 2024-05-13 | $9.61M derived: sum of 2 quarters · filed 2024-05-13 | $15.31M derived: sum of 3 quarters · filed 2024-05-13 | $39.73M derived: sum of 4 quarters · filed 2024-05-13 | |||||
| 2022-12-31 | $4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $10.20M derived: sum of 2 quarters · filed 2024-03-28 | $34.62M derived: sum of 3 quarters · filed 2024-03-28 | $38.83M 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | $5.69M 10-Q · filed 2023-11-13 | $30.12M derived: sum of 2 quarters · filed 2023-11-13 | $34.33M 10-Q · filed 2023-11-13 | $38.03M derived: sum of 4 quarters · filed 2023-11-13 | |||||
| 2022-06-30 | $24.43M 10-Q · filed 2023-08-14 | $28.63M 10-Q · filed 2023-08-14 | $32.34M derived: sum of 3 quarters · filed 2023-08-14 | $36.29M derived: sum of 4 quarters · filed 2023-08-14 | |||||
| 2022-03-31 | $4.21M 10-Q · filed 2023-05-15 | $7.91M derived: sum of 2 quarters · filed 2023-05-15 | $11.86M derived: sum of 3 quarters · filed 2023-05-15 | $15.69M derived: sum of 4 quarters · filed 2023-05-15 | |||||
| 2021-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $7.66M derived: sum of 2 quarters · filed 2023-03-29 | $11.48M derived: sum of 3 quarters · filed 2023-03-29 | $14.22M 10-K · filed 2023-03-29 | |||||
| 2021-09-30 | $3.95M 10-Q · filed 2022-11-14 | $7.78M derived: sum of 2 quarters · filed 2022-11-14 | $10.52M 10-Q · filed 2022-11-14 | $12.49M derived: sum of 4 quarters · filed 2022-11-14 | |||||
| 2021-06-30 | $3.83M 10-Q · filed 2022-08-15 | $6.57M 10-Q · filed 2022-08-15 | $8.54M derived: sum of 3 quarters · filed 2022-08-15 | $11.74M derived: sum of 4 quarters · filed 2022-08-15 | |||||
| 2021-03-31 | $2.74M 10-Q · filed 2022-05-11 | $4.71M derived: sum of 2 quarters · filed 2022-05-11 | $7.91M derived: sum of 3 quarters · filed 2022-05-11 | $11.92M derived: sum of 4 quarters · filed 2022-05-11 | |||||
| 2020-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $5.17M derived: sum of 2 quarters · filed 2022-03-23 | $9.18M derived: sum of 3 quarters · filed 2022-03-23 | $11.60M 10-K · filed 2022-03-23 | |||||
| 2020-09-30 | $3.20M 10-Q · filed 2021-11-15 | $7.20M derived: sum of 2 quarters · filed 2021-11-15 | $9.62M 10-Q · filed 2021-11-15 | $57.95M derived: sum of 4 quarters · filed 2021-11-15 | |||||
| 2020-06-30 | $4.00M 10-Q · filed 2021-08-16 | $6.43M 10-Q · filed 2021-08-16 | $54.75M derived: sum of 3 quarters · filed 2021-08-16 | $57.05M derived: sum of 4 quarters · filed 2021-08-16 | |||||
| 2020-03-31 | $2.42M 10-Q · filed 2021-05-17 | $50.75M derived: sum of 2 quarters · filed 2021-05-17 | $53.05M derived: sum of 3 quarters · filed 2021-05-17 | $55.19M derived: sum of 4 quarters · filed 2021-05-17 | |||||
| 2019-12-31 | $48.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $50.63M derived: sum of 2 quarters · filed 2021-03-17 | $52.77M derived: sum of 3 quarters · filed 2021-03-17 | $54.97M 10-K · filed 2021-03-17 | |||||
| 2019-09-30 | $2.30M 10-Q · filed 2020-11-13 | $4.44M derived: sum of 2 quarters · filed 2020-11-13 | $6.64M 10-Q · filed 2020-11-13 | $62.95M derived: sum of 4 quarters · filed 2020-11-13 | |||||
| 2019-06-30 | $2.14M 10-Q · filed 2020-08-06 | $4.34M 10-Q · filed 2020-08-06 | $60.65M derived: sum of 3 quarters · filed 2020-08-06 | $63.06M derived: sum of 4 quarters · filed 2020-08-06 | |||||
| 2019-03-31 | $2.20M 10-Q · filed 2020-05-13 | $58.50M derived: sum of 2 quarters · filed 2020-05-13 | $60.92M derived: sum of 3 quarters · filed 2020-05-13 | $63.05M derived: sum of 4 quarters · filed 2020-05-13 | |||||
| 2018-12-31 | $56.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $58.72M derived: sum of 2 quarters · filed 2020-03-27 | $60.85M derived: sum of 3 quarters · filed 2020-03-27 | $62.92M 10-K · filed 2020-03-27 | |||||
| 2018-09-30 | $2.42M 10-Q · filed 2019-11-12 | $4.55M derived: sum of 2 quarters · filed 2019-11-12 | $6.62M 10-Q · filed 2019-11-12 | $8.45M derived: sum of 4 quarters · filed 2019-11-12 | |||||
| 2018-06-30 | $2.13M 10-Q · filed 2019-08-09 | $4.20M 10-Q · filed 2019-08-09 | $6.03M derived: sum of 3 quarters · filed 2019-08-09 | $8.14M derived: sum of 4 quarters · filed 2019-08-09 | |||||
| 2018-03-31 | $2.07M 10-Q · filed 2019-05-10 | $3.90M derived: sum of 2 quarters · filed 2019-05-10 | $6.01M derived: sum of 3 quarters · filed 2019-05-10 | $8.12M derived: sum of 4 quarters · filed 2019-05-10 | |||||
| 2017-12-31 | $1.83M 10-K · filed 2018-03-21 | $3.94M derived: sum of 2 quarters · filed 2018-03-21 | $6.05M derived: sum of 3 quarters · filed 2018-11-09 | $8.26M 10-K · filed 2019-04-01 | |||||
| 2017-09-30 | $2.11M 10-K · filed 2018-03-21 | $4.22M derived: sum of 2 quarters · filed 2018-11-09 | $6.43M 10-Q · filed 2018-11-09 | $101.73M derived: sum of 4 quarters · filed 2018-11-09 | |||||
| 2017-06-30 | $2.11M 10-Q · filed 2018-11-09 | $1.20M 10-Q · filed 2017-08-08 | $4.32M 10-Q · filed 2018-08-09 | $99.62M derived: sum of 3 quarters · filed 2018-11-09 | $101.51M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-03-31 | $3.12M 10-Q · filed 2018-05-10 | $97.51M derived: sum of 2 quarters · filed 2018-05-10 | $99.40M derived: sum of 3 quarters · filed 2018-05-10 | $103.61M derived: sum of 4 quarters · filed 2018-05-10 | |||||
| 2016-12-31 | $94.39M 10-K · filed 2018-03-21 | $96.28M derived: sum of 2 quarters · filed 2018-03-21 | $100.48M derived: sum of 3 quarters · filed 2018-03-21 | $105.82M 10-K · filed 2018-03-21 | |||||
| 2016-09-30 | $1.89M 10-K · filed 2018-03-21 | $6.10M derived: sum of 2 quarters · filed 2018-03-21 | $11.43M 10-Q · filed 2017-11-08 | $55.80M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2016-06-30 | $4.20M 10-K · filed 2018-03-21 | $9.54M 10-Q · filed 2017-08-08 | $53.91M derived: sum of 3 quarters · filed 2018-03-21 | $57.52M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2016-03-31 | $5.33M 10-K · filed 2018-03-21 | $49.71M derived: sum of 2 quarters · filed 2018-03-21 | $53.32M derived: sum of 3 quarters · filed 2018-03-21 | $57.16M derived: sum of 4 quarters · filed 2018-03-21 | |||||
| 2015-12-31 | $44.37M 10-K · filed 2017-03-31 | $47.99M derived: sum of 2 quarters · filed 2017-03-31 | $51.83M derived: sum of 3 quarters · filed 2017-03-31 | $54.03M 10-K · filed 2018-03-21 | |||||
| 2015-09-30 | $3.61M 10-K · filed 2017-03-31 | $7.46M derived: sum of 2 quarters · filed 2017-03-31 | $9.65M 10-Q · filed 2016-11-09 | $11.32M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2015-06-30 | $3.84M 10-K · filed 2017-03-31 | $6.04M 10-Q · filed 2016-08-09 | $7.71M derived: sum of 3 quarters · filed 2017-03-31 | $8.93M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2015-03-31 | $2.19M 10-K · filed 2017-03-31 | $3.86M derived: sum of 2 quarters · filed 2017-03-31 | $5.08M derived: sum of 3 quarters · filed 2017-03-31 | $6.47M derived: sum of 4 quarters · filed 2017-03-31 | |||||
| 2014-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $2.89M derived: sum of 2 quarters · filed 2017-03-31 | $4.28M derived: sum of 3 quarters · filed 2017-03-31 | $5.81M 10-K · filed 2017-03-31 | |||||
| 2014-09-30 | $1.22M 10-Q · filed 2015-11-16 | $2.61M derived: sum of 2 quarters · filed 2015-11-16 | $4.14M 10-Q · filed 2015-11-16 | $5.12M derived: sum of 4 quarters · filed 2015-11-16 | |||||
| 2014-06-30 | $1.39M 10-Q · filed 2015-08-14 | $2.92M 10-Q · filed 2015-08-14 | $3.90M derived: sum of 3 quarters · filed 2015-08-14 | $4.91M derived: sum of 4 quarters · filed 2015-08-14 | |||||
| 2014-03-31 | $1.53M 10-Q · filed 2015-05-14 | -$1.53M 10-Q · filed 2014-05-15 | $2.52M derived: sum of 2 quarters · filed 2015-05-14 | $3.52M derived: sum of 3 quarters · filed 2015-05-14 | $4.55M derived: sum of 4 quarters · filed 2015-05-14 | $18.81M 10-Q · filed 2014-05-15 | |||
| 2013-12-31 | $986.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $1.99M derived: sum of 2 quarters · filed 2015-03-31 | $3.02M derived: sum of 3 quarters · filed 2015-03-31 | $4.08M 10-K · filed 2015-03-31 | $3.30M 10-K · filed 2014-03-31 | ||||
| 2013-09-30 | $1.00M 10-Q · filed 2014-11-14 | $1.52M 10-Q · filed 2013-11-18 | $2.04M derived: sum of 2 quarters · filed 2014-11-14 | $3.10M 10-Q · filed 2014-11-14 | $4.35M 10-Q · filed 2013-11-18 | $419.41K derived: sum of 4 quarters · filed 2014-11-14 | |||
| 2013-06-30 | $1.03M 10-Q · filed 2014-08-14 | $1.29M 10-Q · filed 2013-08-15 | $2.09M 10-Q · filed 2014-08-14 | $2.90M 10-Q · filed 2013-08-15 | -$585.59K derived: sum of 3 quarters · filed 2014-08-14 | $982.13K derived: sum of 4 quarters · filed 2014-08-14 | |||
| 2013-03-31 | $1.06M 10-Q · filed 2014-05-15 | $1.61M 10-Q · filed 2013-05-10 | -$1.62M derived: sum of 2 quarters · filed 2014-05-15 | -$48.87K derived: sum of 3 quarters · filed 2014-05-15 | $1.72M derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | -$2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | -$1.11M derived: sum of 2 quarters · filed 2014-03-31 | $661.11K derived: sum of 3 quarters · filed 2014-03-31 | $2.55M 10-K · filed 2014-03-31 | $9.86M 10-K · filed 2013-04-01 | ||||
| 2012-09-30 | $1.57M 10-Q · filed 2013-11-18 | $1.66M 10-Q · filed 2012-11-14 | $3.34M derived: sum of 2 quarters · filed 2013-11-18 | $5.23M 10-Q · filed 2013-11-18 | $5.46M 10-Q · filed 2012-11-14 | $5.11M derived: sum of 4 quarters · filed 2013-11-18 | |||
| 2012-06-30 | $1.77M 10-Q · filed 2013-08-15 | $3.80M 10-Q · filed 2013-08-15 | $3.54M derived: sum of 3 quarters · filed 2013-08-15 | $7.85M derived: sum of 4 quarters · filed 2013-08-15 | |||||
| 2012-03-31 | $2.04M 10-Q · filed 2013-05-10 | $2.32M 10-Q · filed 2012-05-21 | $1.78M derived: sum of 2 quarters · filed 2013-05-10 | $6.08M derived: sum of 3 quarters · filed 2013-05-10 | $7.42M derived: sum of 4 quarters · filed 2013-05-10 | ||||
| 2011-12-31 | -$261.06K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01 | $4.04M derived: sum of 2 quarters · filed 2013-04-01 | $5.38M derived: sum of 3 quarters · filed 2013-04-01 | $6.57M 10-K · filed 2013-04-01 | $7.85M 10-K · filed 2012-04-16 | ||||
| 2011-09-30 | $4.30M 10-Q · filed 2012-11-14 | $4.00M 10-Q · filed 2011-11-21 | $5.64M derived: sum of 2 quarters · filed 2012-11-14 | $6.83M 10-Q · filed 2012-11-14 | $7.38M 10-Q · filed 2011-11-21 | $8.84M derived: sum of 4 quarters · filed 2012-11-14 | |||
| 2011-06-30 | $1.34M 10-Q/A · filed 2012-09-28 | $1.72M 10-Q/A · filed 2011-09-09 | $2.53M 10-Q/A · filed 2012-09-28 | $3.37M 10-Q/A · filed 2011-09-09 | $4.54M derived: sum of 3 quarters · filed 2012-10-02 | $6.36M derived: sum of 4 quarters · filed 2012-10-02 | |||
| 2011-03-31 | $1.20M 10-Q/A · filed 2012-10-02 | $1.59M 10-Q · filed 2012-05-21 | $3.19M derived: sum of 2 quarters · filed 2012-10-02 | $5.02M derived: sum of 3 quarters · filed 2012-10-02 | $6.47M derived: sum of 4 quarters · filed 2012-10-02 | ||||
| 2010-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $3.83M derived: sum of 2 quarters · filed 2012-04-16 | $5.28M derived: sum of 3 quarters · filed 2012-04-16 | $6.86M 10-K · filed 2012-04-16 | |||||
| 2010-09-30 | $1.83M 10-Q · filed 2011-11-21 | $3.28M derived: sum of 2 quarters · filed 2011-11-21 | $4.86M 10-Q · filed 2011-11-21 | ||||||
| 2010-06-30 | $1.45M 10-Q/A · filed 2011-09-09 | $3.03M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |